CRBU

MKT CAP:$231M

Caribou Biosciences Inc

Market Cap

$231M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.92+$0.33 (+20.75%)

Jun 5, 2026

52W High $2.8452W Low $1.11

Company Details

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA gen...

CEO

—

IPO Date

Jul 23, 2021

Website

cariboubio.com

Key Metrics TTM

Revenue

$11M

+13.0% YoY

Net Income

-$133M

EPS (Diluted)

Free Cash Flow

-$102M

Revenue / Share

$0.12

Gross Margin

94.2%

Operating Margin

-1175.7%

Net Margin

-1189.1%

FCF Margin

-907.3%

P/S

20.6x

P/E

Earnings Reports

Q1 2026

May 7, 2026

$2M+1.9%

FY 2025

Mar 5, 2026

$11M+11.7%

Q4 2025

Mar 5, 2026

$4M+89.7%

Q3 2025

Nov 12, 2025

$2M+8.6%

Q2 2025

Aug 12, 2025

$3M-23.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee